Indications
Treatment of narcolepsy with cataplexy in adult patients.
Composition
- Active substance
- sodium oxybate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Xyrem
- Active substance
- sodium oxybate
- ATC code
- N07XX04
- Group
- Nervous system
- Therapeutic area
- Cataplexy, Narcolepsy
- Marketing authorisation holder
- UCB Pharma Ltd
- Status
- Authorised
- EU authorisation
- 13 Oct 2005
- EMA product number
- EMEA/H/C/000593